MODD VS TXMD Stock Comparison

Performance

MODD
10/100

MODD returned -66.69% in the last 12 months. Based on SPY's performance of -13.85%, its performance is below average giving it a score of 10 of 100.

TXMD
10/100

TXMD returned -65.46% in the last 12 months. Based on SPY's performance of 13.09%, its performance is below average giving it a score of 10 of 100.

Technicals

MODD
29/100

MODD receives a 28 of 100 based on 14 indicators. 3 are bullish, 9 are bearish.

TXMD
11/100

TXMD receives a 10 of 100 based on 14 indicators. 1 are bullish, 12 are bearish.

Earnings

MODD
21/100

MODD has missed earnings 3 times in the last 20 quarters.

TXMD
10/100

TXMD has missed earnings 12 times in the last 20 quarters.

Profit

MODD
10/100

Out of the last 20 quarters, MODD has had 0 profitable quarters and has increased their profits year over year on 0 of them.

TXMD
10/100

Out of the last 20 quarters, TXMD has had 1 profitable quarters and has increased their profits year over year on 1 of them.

Volatility

MODD
41/100

MODD has had a lower than average amount of volatility over the last 12 months giving it a score of 40 of 100.

TXMD
45/100

TXMD has had a lower than average amount of volatility over the last 12 months giving it a score of 44 of 100.

Analyst Price Targets

MODD

"Analyst Price Targets" not found for MODD

TXMD
81/100

9 analysts offer 12-month price targets for TXMD. Together, they have an average target of 0, the most optimistic target put TXMD at 0 within 12-months and the most pessimistic has TXMD at 0.

Sentiment

MODD

"Sentiment" not found for MODD

TXMD
69/100

TXMD had a bullish sentiment score of 69.10% across Twitter and StockTwits over the last 12 months. It had an average of 2.85 posts, 0.59 comments, and 1.96 likes per day.

All score calculations are broken down here to help you make more informed investing decisions

Modular Medical, Inc. Common Stock Summary

Nasdaq / MODD

Healthcare

Medical - Devices

Modular Medical, Inc., a development stage medical device company, focuses on the design, development, and commercialization of insulin pumps using technology to enhance pump adoption in the diabetes marketplace. The company is headquartered in San Diego, California.

TherapeuticsMD, Inc. Summary

Nasdaq / TXMD

Healthcare

Drug Manufacturers - Specialty & Generic

TherapeuticsMD, Inc. operates as a women's healthcare company in the United States. The company offers IMVEXXY for the treatment of moderate-to-severe dyspareunia; BIJUVA, a bio-identical hormone therapy combination of 17ß-estradiol and progesterone for the treatment of moderate-to-severe vasomotor symptoms; and ANNOVERA, a ring-shaped contraceptive vaginal system. Its preclinical projects include the development of TX-005HR, a progesterone-alone transdermal cream; TX-006HR, an estradiol and progesterone transdermal cream; TX-007HR and TX-008HR, which are transdermal patch product candidates; and TX-009HR, an oral progesterone and estradiol formulation. It also manufactures and distributes branded and generic prescription prenatal vitamins under the vitaTrue, vitaPearl, vitaMedMD, and BocaGreenMD Prena1 brands. The company sells its prescription pharmaceutical products and prenatal vitamin products to wholesale distributors and retail pharmacy distributors. TherapeuticsMD, Inc. was founded in 2008 and is headquartered in Boca Raton, Florida.

Power up your portfolio